Mance E. Buttram

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Federal Grant PI

Associate Professor

University of Arkansas

Also affiliated: Florida International University (2014); Nova Southeastern University (2012–2020)

19 h-index 130 pubs 1,277 cited

Research Areas

Biomedical Subjects

Links

ORCID Research Group

OverviewAI-generated summary

Mance E. Buttram's research investigates substance use disorders, particularly in vulnerable populations, and their intersection with infectious diseases and behavioral health. He is the Principal Investigator on a $137,885 grant from the NIH/National Institute on Drug Abuse examining the concomitant non-medical use of gabapentin and opioids. His work has explored various facets of substance use, including prescription opioid misuse among the elderly, the diversion and abuse of extended-release oxycodone, and gabapentin diversion and misuse as identified through law enforcement data.

Buttram's publications also address syndemic factors, resilience, and risk and protective factors among specific demographic groups, including men who have sex with men (MSM) who use substances and are HIV-positive or negative, and African-American female sex workers. His research has examined social support among Black men in relation to substance use and sexual risk, and behavioral interventions for high-risk substance-using MSM. With an h-index of 19 and 130 total publications, Buttram is an active researcher in his field. He leads a research group and has collaborated with several researchers at the University of Arkansas at Fayetteville.

Metrics

h-index: 19
Publications: 130
Citations: 1,277

Positions

Associate Professor 2021–present

University of Arkansas Fayetteville Health, Human Performance & Recreation ORCID

Selected Publications

HIV Pre-Exposure Prophylaxis Awareness among Individuals in Treatment for Opioid Use Disorder in the United States: A Cross-Sectional Study (2026)

AIDS and Behavior DOI OpenAlex
Gabapentin-Related State Policies and Associations with Gabapentin Non-Medical Use Among a Nationally Representative Population in the United States (2025)

Substance Use & Misuse 2 citations DOI OpenAlex
Pharmaceutical stimulant diversion, 2002–2022: data from a national sample of law enforcement and regulatory agencies in the US (2025)

Drugs Education Prevention and Policy DOI OpenAlex
It’s Like Disney … You Have to Find Them a Fantasy: Latino Sexual Minority Men at the Intersection of Tourism, Sex, Drug Use, and HIV in Miami-South Beach (2025)

The Journal of Sex Research DOI OpenAlex
Recreational Ketamine Use among Individuals with Opioid Use Disorder: Demographics, Motivations, and Polysubstance Use (2025)

Substance Use & Misuse 1 citation DOI OpenAlex
Pharmaceutical Stimulant Diversion, 2002-2022: Data from a National Sample of Law Enforcement and Regulatory Agencies (2025)

Drug and Alcohol Dependence DOI OpenAlex
The Informal, Non-Prescribed Use of Antiretroviral Medications for PrEP Among a National US-Based Sample of Gay, Bisexual, and Other Men Who Have Sex with Men: A Cross-Sectional Study (2024)

AIDS and Behavior 2 citations DOI OpenAlex
Understanding Ketamine Use in Treatment-Seeking Persons With Opioid Use Disorder (2024)

Drug and Alcohol Dependence DOI OpenAlex
GABAPENTIN UTILIZATION AMONG BUPRENORPHINE-PRESCRIBED INDIVIDUALS WITH OPIOID USE DISORDER AND ASSOCIATED RISK OF OVERDOSE (2024)

Drug and Alcohol Dependence DOI OpenAlex
Associations Between Kratom-Related State Policy Environments and Kratom Use in a Nationally Representative Population in the United States (2024)

Drug and Alcohol Dependence DOI OpenAlex
Geographic and Racial/Ethnic Differences in Access to Methamphetamine Detoxification Services, United States, 2021 (2024)

Medical Care 4 citations DOI OpenAlex
The impact of socio-environmental factors on doxycycline post-exposure prophylaxis awareness in the US: a cross-sectional study (2024)

Sexual Health 12 citations DOI OpenAlex
Stigma Related to the Non-Medical Use and Diversion of Prescription Stimulant Drugs: Should We Care (2024)

Substance Use & Misuse 2 citations DOI OpenAlex
Gabapentin Use Among Individuals Initiating Buprenorphine Treatment for Opioid Use Disorder (2023)

JAMA Psychiatry 13 citations DOI OpenAlex
Law enforcement experiences with gabapentin: non-medical use, diversion, and state controlled substances laws (2023)

Journal of Substance Use 2 citations DOI OpenAlex